✦ LIBER ✦

1147 5-year follow-up of 998 chronic hepatitis B patients to determine long-term safety of lamivudine and clinical consequences of lamivudine-resistant mutations

✍ Scribed by LOK, A; LAI, C; LEUNG, N; YAO, G; CUI, Z; SCHIFF, E; DIENSTAG, J; HEATHCOTE, J; LITTLE, N; GRIFFITHS, D

Book ID: 122290361
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 122 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/S0270-9139(03)81185-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to long-term lamivudine treatme

Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance

✍ D. N. Moskovitz; C. Osiowy; E. Giles; G. Tomlinson; E. J. Heathcote 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Favorable efficacy of long-term lamivudi

Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: An 8-year follow-up study

✍ Norio Akuta; Fumitaka Suzuki; Yoshiyuki Suzuki; Hitomi Sezaki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract The long‐term efficacy of lamivudine therapy in patients with hepatitis B virus (HBV) infection is still not clear. In this study, 20 non‐cirrhotic Japanese patients infected with HBV received lamivudine therapy for more than 1 year and were followed for a median period of 8.5 years (ra